GRFS Stock: Price, Forecast, Financials & AI Analysis

High

Open

VWAP

Vol

Mkt Cap

Low

Amount

EV/EBITDA(TTM)

Total Shares

EV/OCF(TTM)

P/S(TTM)

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2025Q2

FY2025Q3

FY2025Q4

1.88B

+3.63%

1.86B

+3.65%

1.90B

-3.62%

Estimates Revision

The market is revising Downward the revenue expectations for Grifols, S.A. (GRFS) for FY2025, with the revenue forecasts being adjusted by -0.4% over the past three months. During the same period, the stock price has changed by -1.26%.

Revenue Estimates for FY2025

Revise Downward

-0.4%

In Past 3 Month

EPS Estimates for FY2025

Revise Downward

-2.76%

In Past 3 Month

Stock Price

Go Down

-1.26%

In Past 3 Month

Valuation Metrics

The current forward P/E ratio for Grifols SA (GRFS.O) is 12.19, compared to its 5-year average forward P/E of 16.49. For a more detailed relative valuation and DCF analysis to assess Grifols SA 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

5Y Average PE

16.49

Current PE

12.19

Overvalued PE

23.19

Undervalued PE

9.79

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

5Y Average EV/EBITDA

12.07

Current EV/EBITDA

9.32

Overvalued EV/EBITDA

14.63

Undervalued EV/EBITDA

9.51

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

5Y Average PS

1.27

Current PS

0.87

Overvalued PS

1.87

Undervalued PS

0.67

Financials

Annual

Quarterly

N/A

Total Revenue

N/A

Operating Profit

N/A

Net Income after Tax

N/A

EPS - Diluted

N/A

Free Cash Flow

N/A

Gross Profit Margin - %

N/A

FCF Margin - %

N/A

Net Margin - %

N/A

ROIC

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Hedge Fund

Hedge Funds areSelling! The selling amount has increased 986.97% over the last quarter.

Sold

Bought

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

GRFS News & Events

Events Timeline

No data

News

9.0

2025-12-19NASDAQ.COM

Grifols Obtains FDA Approval to Introduce Fesilty in the US by Mid-2026

4.0

2025-11-26NASDAQ.COM

Daily Upgrade Report for Validea's Joseph Piotroski Strategy - November 26, 2025

4.0

2025-10-10NASDAQ.COM

Daily Upgrade Report for Validea's Joseph Piotroski Strategy - October 10, 2025

People Also Watch

Frequently Asked Questions

What is Grifols SA (GRFS) stock price today?

The current price of GRFS is 9.37 USD — it has decreased -1.26 % in the last trading day.

What is Grifols SA (GRFS)'s business?

Grifols SA is a Spain-based global specialty pharmaceutical company developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. The Company organizes its business into five divisions: Bioscience, Diagnostic, Hospital, Bio Supplies and Others. Bioscience includes manufacturing activities of plasma derivatives for therapeutic use and the sale and distribution of end products. Its diagnostic focuses on researching, developing, manufacturing and marketing in vitro diagnostics products, such as analytical instruments, reagents and software, among others, for laboratories. Hospital offers technology and services for hospitals, clinics and specialized centers for the manufacture of medicines, as well as physiological saline solution, enteral nutritional fluids and medical devices for interventional therapy. Its bio Supplies provides, mostly, biological products for non-therapeutic use.

What is the price predicton of GRFS Stock?

Wall Street analysts forecast GRFS stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for GRFS is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Grifols SA (GRFS)'s revenue for the last quarter?

Grifols SA revenue for the last quarter amounts to 2.18B USD, increased 10.68 % YoY.

What is Grifols SA (GRFS)'s earnings per share (EPS) for the last quarter?

Grifols SA. EPS for the last quarter amounts to 0.22 USD, increased 175.00 % YoY.

What changes have occurred in the market's expectations for Grifols SA (GRFS)'s fundamentals?

How many employees does Grifols SA (GRFS). have?

Grifols SA (GRFS) has 23833 emplpoyees as of January 10 2026.

What is Grifols SA (GRFS) market cap?

Today GRFS has the market capitalization of 6.38B USD.